Bond.az White LogoBond.az Black Logo

FIBK under balance sheet pressure

First Interstate BancSystem (FIBK) faces balance sheet pressure and weak loan production, leading analysts to cut earnings estimates. Shares may be undervalued.

Sebastian Young
BySebastian Young- Senior Editor
|
0

First Interstate BancSystem (NASDAQ:FIBK) faces challenges in balance sheet optimization as loan production falls below expectations.

The Montana-based company's assets are shrinking. Analysts have lowered earnings forecasts. Management prioritizes share buybacks.

FIBK's P/E ratio is 11.57, PEG ratio 0.24, suggesting undervaluation. Market cap stands at $3.45 billion, share price at $35.49.

Analysts cut first fiscal year EPS estimate from $2.62 to $2.56. Second year estimate rose from $2.85 to $3.05.

The company has paid dividends for 17 consecutive years. Current dividend yield is 5.3%. Management accelerated share repurchases.

The industry outlook for mid-cap banks remains positive, providing a favorable backdrop for FIBK.

Barclays Capital confirmed a price target of $36 with an Equal Weight rating.

For more information, visit Bond.az.

More News
2026-05-26 01:03
|
270

Lennar SWOT analysis: homebuilder stock under pressure

Lennar SWOT analysis: margin pressure, leadership changes, and strategic transformation. Learn the impact on the stock.

0
2026-05-26 00:32
|
817

Group 1 Automotive SWOT: UK Headwinds Impact Stock

Group 1 Automotive SWOT analysis: UK market headwinds, US growth opportunities, and GPI stock valuation.

0
2026-05-26 00:30
|
233

Lumentum: Optical Stock Poised for AI Data Center Growth

Lumentum Holdings is poised for growth with AI data center demand. Exclusive NVIDIA partnership and 50%+ market share in optical components.

0
2026-05-26 00:04
|
842

Lowe's SWOT analysis: stock faces rate headwinds

Lowe's SWOT analysis: interest rates, aging housing stock, and competitive landscape impacting the stock.

0
2026-05-25 23:31
|
761

Equinix SWOT analysis: data center growth amid AI demand

Equinix SWOT analysis: Data center expansion strategy, financials, risks, and opportunities in the AI-driven market.

0
2026-05-25 23:00
|
519

Benitec Biopharma gene therapy stock shows clinical promise

Benitec Biopharma gene therapy stock shows clinical promise. BB-301 achieves 100% response rate in OPMD. Analysis on Bond.az.

0
2026-05-25 22:33
|
434

Rollins SWOT Analysis: Pest Stock at Premium Valuation

Rollins Inc. SWOT analysis: pest control stock navigates premium valuation, growth prospects, and risks.

0
2026-05-25 22:30
|
757

Invesco SWOT: Growth vs Costs

Invesco SWOT analysis: strong revenue growth but rising costs. Positioned with ETF and QQQ strategies.

0
2026-05-25 22:00
|
933

Visteon SWOT Analysis: Stock Eyes Recovery

Visteon Corporation SWOT analysis: automotive electronics supplier's recovery potential in 2026. Key partnerships with Toyota, Honda, NVIDIA, Qualcomm and financial targets.

0
2026-05-25 21:32
|
864

MSCI SWOT Analysis: Stock Shows Strong Momentum

MSCI SWOT analysis: Strong Index subscription momentum, ABF outperformance, and growth opportunities in AI and private assets. Barclays maintains Overweight rating with $700 price target.

0
2026-05-25 21:30
|
269

NXP Semiconductors SWOT analysis

NXP Semiconductors SWOT analysis: strengths, weaknesses, opportunities, and threats. Position in the semiconductor industry and future prospects.

0
2026-05-25 21:01
|
600

W.R. Berkley stock faces growth concerns

W.R. Berkley stock faces premium growth slowdown and reserve pressures. Bond.az analysis provides insights for informed investment decisions.

0
...